|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,901 JPY | +1.32% |
|
-2.32% | -16.32% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Apr. 01 | BioArctic, Eisai Seek US FDA Approval for Maintenance Dose of Alzheimer’s Disease Drug | MT |
Attachments
Disclaimer
Eisai Co. Ltd. published this content on 06 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 June 2022 23:41:02 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.32% | 10.8B | |
| +27.97% | 672B | |
| +23.58% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.96% | 211B | |
| -0.41% | 203B | |
| -10.02% | 194B | |
| -11.81% | 144B |
EISAI CO., LTD. 
